2026 New Members

Meredith P. Schuh, MD, is a pediatric nephrologist in the Division of Nephrology & Hypertension at Cincinnati Children’s Hospital Medical Center, with a secondary appointment in the Division of Developmental Biology.

Her research focuses on the molecular mechanisms underlying normal and abnormal kidney development during late gestation, as well as the impact of neonatal exposures on the development of acute and chronic kidney disease. Clinically, she specializes in fetal care and neonatal nephrology

Drew Schwartz, MD, PhD is a physician-scientist and Assistant Professor in the Department of Pediatrics, Division of Infectious Diseases at Washington University School of Medicine in St. Louis. He completed his undergraduate training at Duke University with a double major in Chemistry and Biology followed by the Medical Scientist Training Program at Washington University School of Medicine.

Dr. Schwartz’s laboratory utilizes gut microbiome culturing and sequencing, immune profiling, and computational analyses in clinical cohorts and mechanistic, gnotobiotic animal models to investigate how the pediatric gut microbiome and immune response develop and are disrupted leading to serious bacterial infections. His goal is to utilize predictive computational algorithms and gut microbiome profiling to better identify children at risk of sepsis and provide personalized antibiotic recommendations and stewardship. He has been funded by the Thrasher Research Fund, Doris Duke Foundation, and through NIH NIAID K08 and NICHD R56 awards. In his spare time, he enjoys board games, basketball, and cycling.

Dr. Kelsey Schweiberger, MD, MS is a general pediatrician, health services researcher, clinical informatician, and an Assistant Professor of Pediatrics at the University of Pittsburgh School of Medicine. Dr. Schweiberger earned her Bachelor of Science degree from Georgetown University, completed medical school at the Herbert Wertheim College of Medicine at Florida International University, and her Masters of Clinical Research at the University of Pittsburgh. She completed general pediatrics residency at UPMC Children’s Hospital of Pittsburgh and a primary care research and learning health system fellowship at the University of Pittsburgh. Dr. Schweiberger’s research program is currently supported by an NCATS KL2 and aims to integrate health services research, quality improvement, and clinical informatics to improve child health outcomes through the appropriate application of technology with a current focus on the enrollment and utilization of a pediatric patient portal.

Dr. Seske began her research career focusing on improving neonatal outcomes through rigorous, interprofessional research during her fellowship by publishing several studies regarding infant mortality, cause of death, and vital records reporting. Dr. Seske also began her career in Quality Improvement and Patient Safety by participating in the Solutions for Patient Safety Unplanned Extubation initiative during fellowship. Dr. Seske’s research focuses on Quality Improvement and Patient Safety outcomes data, including various hospital metrics such as length of stay and cost of healthcare resource utilization. Dr. Seske was a Co-Investigator for a Master of Health Systems Management’s thesis project, which was accepted for publication studying discharge readiness and optimizing length of stay in the NICU. Dr. Seske also served as the PI for a Pediatric Resident’s research project analyzing healthcare utilization and cost of patients in the NICU who underwent neurosurgical procedures, which was also published.   Dr. Seske’s publication record exhibits her excellent research productivity. Her key role in these publications is demonstrated by her order of authorship. Dr. Seske has authored 14 peer reviewed publications: having been first (8), second (1), and senior (5). Six manuscripts have been published since 2019. Dr. Seske’s publications are in prominent journals including Maternal and Child Health. One first author original research article on Infant Mortality and Vital Records Reporting was first-of-its-kind.   At RUMC, she has mentored multiple trainees resulting in 4 peer reviewed publications and abstracts presented at various conferences. One of the abstracts was awarded Best Poster Winner for Clinical Excellence and Top Quality at the Rush Quality and Safety Fair 2022. Dr. Seske also received a Copyright for intellectual property of a patient care bundle developed while at RUMC. In short, Dr. Seske has made tremendous contributions to the field while providing excellent mentorship to trainees highlighting the interprofessional work necessary to enhance neonatal outcomes.

Dr. Shulman is a Pediatric Oncologist, a clinical/translational researcher at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center (DFCI/BCH), and an Assistant Professor of Pediatrics at Harvard Medical School (HMS). His research focuses on improving outcomes for adolescents and young adults (AYA) with sarcomas through investigation of novel biomarkers and therapies.

His clinical focus is on the care of AYAs (40 years and younger) with sarcomas. He is the director of the DFCI AYA Sarcoma Program, which is dedicated to improving outcomes for AYAs with sarcomas through comprehensive clinical care and collaborative research.

Dr. Yogen Singh is a Full Professor of Pediatrics at the University of California – UC Davis Children’s Hospital, California. He is the Founder and Chair of the ESPNIC POCUS Working Group. As a Pediatrician with Expertise in Pediatric cardiology, he is formally trained in comprehensive structural and functional echocardiography. He is truly passionate about Targeted Neonatal Echocardiography (TNE), neonatal hemodynamics and point-of-care ultrasound (POCUS) training for the neonatal and pediatric intensivists so that they can be widely applied while making clinical decisions in emergency situations.

He has led development of the “International evidence-based POCUS guidelines for use in neonatal and pediatric intensive care unit”, “Recommendations for hemodynamic monitoring for critically ill children-expert consensus statement”, and “Expert Consensus Statement on Neonatologist Performed Echocardiography (NPE): Training and Accreditation in the UK”. He has contributed to the development of TNE guidelines (2024) and European NPE guidelines. He has a special interest in neonatal and pediatric hemodynamics and advanced functional echocardiography imaging. He is the Director of TNE, Neonatal Hemodynamics and POCUS at UC Davis Children’s Hospital.
Prof. Yogen Singh is the Chief Editor for the world’s first POCUS book textbook for neonatal and pediatric intensivist. He is Co-Director at ‘Point-of-care Echocardiography Course at University of Southern California (USC), Los Angeles, California, USA’ and Training in Intensive Care and Neonatal echocardiography (TINEC) course in Switzerland.

He has published extensively in the peer review journals, especially neonatal hemodynamics and neonatal cardiology – published over 125 papers and scholarly articles in the peer reviewed journals, published one textbook, one eBook and >25 book chapters. He is an Associate Editor, for Frontiers in Pediatrics (Neonatology). As an invited speaker, he has been delivered >100 lectures in the prestigious national and international conferences. He has conducted >100 neonatal echocardiography and POCUS courses in the USA, UK, Europe, Middle East and beyond.

Dr. Cara Slagle is a neonatologist and physician-scientist at Indiana University School of Medicine and Riley Hospital for Children. Her academic focus is neonatal kidney health, with a particular emphasis on acute kidney injury (AKI), fluid imbalance, and neonatal dialysis. Dr. Slagle has helped define how urine biomarkers can be used to proactively detect kidney injury, improve screening to reduce nephrotoxin exposure related AKI, and guide fluid management in critically ill neonates. She currently leads the Improving CRRT Outcomes in Neonates and Infants through Interdisciplinary Collaboration (ICONIIC) Learning Health Network, which spans both QI and Research.   In addition to her research leadership, Dr. Slagle has helped implement AKI screening protocols in NICUs, developed clinical decision-support tools, and led efforts to establish neonatal dialysis programs in Level IV NICUs. She currently serves on the board of the Neonatal Kidney Collaborative and has co-authored national consensus statements on AKI risk stratification and long-term kidney monitoring for NICU graduates. Through her innovative, collaborative work, Dr. Slagle continues to shape the future of neonatal nephrology by integrating cutting-edge science with bedside care to improve short- and long-term outcomes for neonates and infants.

Dr. Jennifer Snaman is a clinician investigator in pediatric palliative care and pediatric oncology and the Director of Pediatric Palliative Care Research at Dana-Farber Cancer Institute and Boston Children’s Hospital. Her research focuses on amplifying the patient voice in decision-making among adolescents and young adults (AYA) with advanced cancer. In partnership with bereaved parents, her work has illuminated the early bereavement experience following a child’s death from cancer, emphasizing the critical role of clinicians, care teams, and healthcare institutions in supporting families during the first years after loss.

Dr. Snaman’s aims to develop innovative, evidence-based strategies to strengthen communication, decision-making, and bereavement support for patients and families affected by pediatric cancer. She co-leads the Palliative Care and Resilience (PCAR) Lab, which includes six interprofessional pediatric researchers and around 20 early career mentees focused on improving care for seriously ill children and those that care for them.

Dr. Nicole T. Spillane is the Associate Director of Neonatology at Hackensack University Medical Center and an Associate Professor at Hackensack Meridian School of Medicine. She obtained her M.D. from University of Massachusetts School of Medicine, and completed her pediatric residency at The Mount Sinai Hospital (New York, NY) and her neonatal-perinatal fellowship at New York Presbyterian-Columbia University Medical Center (New York, NY).

Her research and quality improvement focuses on neonatal resuscitation. Current studies include an innovative code cart design to improve efficiency in advanced resuscitation, delivery room management of term infants with mild respiratory distress, and use of early lung ultrasound scores to predict respiratory decompensation in late preterm infants. Dr. Nicole Spillane is the Chair of the Membership Committee for the Eastern Society for Pediatric Research, the site-PI for the DRIVE Collaborative and the SUGAR trial, a co-investigator on the multi-center NIH ECHO grant “Enriching ECHO Cohorts with High-Risk Pregnancies and Children with Disabilities”, and serves on the Board of Trustees for The Consortium for Maternal Child Health of Northern New Jersey.